Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Tostain

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Cancer|July 20, 2007
C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patientsPierre I Karakiewicz, Georg C Hutterer, Quoc-Dien Trinh, et al.
Cancer|May 14, 2008
Validation by calibration of the UCLA integrated staging system prognostic model for nonmetastatic renal cell carcinoma after nephrectomyLuca Cindolo, Paolo Chiodini, Ciro Gallo, et al.
Anticancer Research|December 11, 2012
Prognostic value of serum CA9 in patients with metastatic clear cell renal cell carcinoma under targeted therapyMarc Gigante, Guorong Li, Celine Ferlay, et al.
Plos One|November 11, 2009
Tissue compartment analysis for biomarker discovery by gene expression profilingAntoine Disset, Lydie Cheval, Olga Soutourina, et al.
Urology|April 19, 2005
Chromophobe renal cell carcinoma: comprehensive analysis of 104 cases from multicenter European databaseLuca Cindolo, Alexandre de la Taille, Luigi Schips, et al.
Journal of Endourology|July 28, 2012
First clinical experience in urologic surgery with a novel robotic lightweight laparoscope holderJean-Alexandre Long, Jacques Tostain, Cecilia Lanchon, et al.
Cancer|January 31, 2007
Prognostic ability of simplified nuclear grading of renal cell carcinomaNathalie Rioux-Leclercq, Pierre I Karakiewicz, Quoc-Dien Trinh, et al.
European Journal of Cancer (Oxford, England : 1990)|March 14, 2007
ECOG performance status 0 or 1 and symptom classification do not improve the ability to predict renal cell carcinoma-specific survivalPierre I Karakiewicz, Quoc-Dien Trinh, Alexandre de la Taille, et al.
The Journal of Urology|August 18, 2004
Multi-institutional validation of a symptom based classification for renal cell carcinomaJean-Jacques Patard, Emmanuelle Leray, Luca Cindolo, et al.
BJU International|December 17, 2008
Cancer-specific and non-cancer-related mortality rates in European patients with T1a and T1b renal cell carcinomaLaurent Zini, Jean-Jacques Patard, Umberto Capitanio, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Cancer|July 20, 2007
C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patientsPierre I Karakiewicz, Georg C Hutterer, Quoc-Dien Trinh, et al.
Cancer|May 14, 2008
Validation by calibration of the UCLA integrated staging system prognostic model for nonmetastatic renal cell carcinoma after nephrectomyLuca Cindolo, Paolo Chiodini, Ciro Gallo, et al.
Anticancer Research|December 11, 2012
Prognostic value of serum CA9 in patients with metastatic clear cell renal cell carcinoma under targeted therapyMarc Gigante, Guorong Li, Celine Ferlay, et al.
Plos One|November 11, 2009
Tissue compartment analysis for biomarker discovery by gene expression profilingAntoine Disset, Lydie Cheval, Olga Soutourina, et al.
Urology|April 19, 2005
Chromophobe renal cell carcinoma: comprehensive analysis of 104 cases from multicenter European databaseLuca Cindolo, Alexandre de la Taille, Luigi Schips, et al.
Journal of Endourology|July 28, 2012
First clinical experience in urologic surgery with a novel robotic lightweight laparoscope holderJean-Alexandre Long, Jacques Tostain, Cecilia Lanchon, et al.
Cancer|January 31, 2007
Prognostic ability of simplified nuclear grading of renal cell carcinomaNathalie Rioux-Leclercq, Pierre I Karakiewicz, Quoc-Dien Trinh, et al.
European Journal of Cancer (Oxford, England : 1990)|March 14, 2007
ECOG performance status 0 or 1 and symptom classification do not improve the ability to predict renal cell carcinoma-specific survivalPierre I Karakiewicz, Quoc-Dien Trinh, Alexandre de la Taille, et al.
The Journal of Urology|August 18, 2004
Multi-institutional validation of a symptom based classification for renal cell carcinomaJean-Jacques Patard, Emmanuelle Leray, Luca Cindolo, et al.
BJU International|December 17, 2008
Cancer-specific and non-cancer-related mortality rates in European patients with T1a and T1b renal cell carcinomaLaurent Zini, Jean-Jacques Patard, Umberto Capitanio, et al.
Pageof 8